Beta-interferon and multiple sclerosis

By Hall G.L.   Compston A.   Scolding N.J.  

Trends in Neurosciences, Vol. 20, Iss. 2, 1997-02 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite

Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b

By Minagar Alireza   Ma Wanlong   Zhang Xi   Wang Xiuqiang   Zhang Ke   Alexander J Steven   Gonzalez-Toledo Eduardo   Albitar Maher  

Neurological Research, Vol. 34, Iss. 6, 2012-07 ,pp. : 611-618

Maney Publishing

Access to resources Recommend Favorite

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis

By Limmroth Volker   Malessa Rolf   Zettl Uwe   Koehler Jürgen   Japp Gudrun   Haller Peter   Elias Wolfgang   Obhof Winfried   Viehöver Andrea   Meier Uwe   Brosig Arne   Hasford Joerg   Putzki Norman   Kalski Gabriele   Wernsdörfer Colin  

Journal of Neurology, Vol. 254, Iss. 1, 2007-01 ,pp. : 67-77

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies

By Scagnolari Carolina   Duda Petra   Bagnato Francesca   Vito Gabriella   Alberelli Alessia   Lavolpe Vito   Girardi Enrico   Durastanti Valentina   Trojano Maria   Kappos Ludwig   Antonelli Guido  

Journal of Neurology, Vol. 254, Iss. 5, 2007-05 ,pp. : 597-604

Springer Publishing Company

Access to resources Recommend Favorite

Interferon beta treatment: Bioavailability and antiviral activity in multiple sclerosis patients

By Garcia-Montojo Marta   Heras Virginia De Las   Bartolome Manuel   Arroyo Rafael   Alvarez-Lafuente Roberto  

Journal of NeuroVirology, Vol. 13, Iss. 6, 2007-11 ,pp. : 504-512

Ashgate Publishing Ltd

Access to resources Recommend Favorite